Oxytocin Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting oxytocin clinical trials across 3 countries. Studies span Phase 2, Early Phase 1, Not Applicable, Phase 4. Top locations include Boston, Massachusetts, United States, Barcelona, Spain, Basel, Switzerland. Updated daily from ClinicalTrials.gov.


Oxytocin Trials at a Glance

8 actively recruiting trials for oxytocin are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Boston, Barcelona, and Basel. Lead sponsors running oxytocin studies include Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Massachusetts General Hospital, and Elizabeth Austen Lawson.

Browse oxytocin trials by phase

Treatments under study

About Oxytocin Clinical Trials

Looking for clinical trials for Oxytocin? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Oxytocin trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Oxytocin clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Early Phase 1

Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

HypopituitarismArginine vasopressin deficiencyOxytocin Deficiency+1 more
Massachusetts General Hospital20 enrolled1 locationNCT07568509
Recruiting
Phase 2

Oxytocin Plus Self-compassion Training in Borderline Personality Disorder

Self-compassion Training (SCT) Plus Intranasal OxytocinSelf-compassion Training (SCT) Plus Intranasal Placebo
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau80 enrolled1 locationNCT07551882
Recruiting
Phase 4

The Stimulation To Induce Mothers Study

Labor PainOxytocinPhysiologic Effects of Drugs+1 more
Yale University988 enrolled3 locationsNCT05079841
Recruiting
Not Applicable

Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU

DepressionMindfulnessAnxiety+8 more
Mayo Clinic40 enrolled1 locationNCT07351799
Recruiting

Sleep Disorders in Hypothalamic and Pituitary Damage

HypopituitarismSleep Wake DisordersHypothalamic Diseases+1 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau60 enrolled1 locationNCT07143266
Recruiting
Phase 2

Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls

Arginine vasopressin deficiencyCentral Diabetes InsipidusOxytocin Deficiency
University Hospital, Basel, Switzerland42 enrolled1 locationNCT06808516
Recruiting
Phase 2

Oxytocin for Weight Loss in Adolescents

Obesity, AdolescentOxytocin
Massachusetts General Hospital75 enrolled1 locationNCT04551482
Recruiting
Early Phase 1

Identifying Oxytocin Deficiency in Adults With Pituitary Disease

Arginine vasopressin deficiencyOxytocin Deficiency
Elizabeth Austen Lawson32 enrolled1 locationNCT06460948